| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP7A ATP7B ATRX PSMC1 MCM3 CHD1 KIF24 DDX11 ACSL3 IQCA1L UBA7 MOCS3 SUPV3L1 ATP11C KIFC3 HSPA9 ATP13A4 DYNC2H1 ANXA1 DDX60 DNAH2 RNF213 ZNFX1 BTAF1 XRCC5 DNAH7 ATP5MG ORC4 CCT6A TRAP1 MACF1 DDX20 MTREX | 1.66e-13 | 614 | 230 | 33 | GO:0140657 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAB11B ATP7A ATP7B ATRX MTG2 RAB11A PSMC1 MCM3 CHD1 GIMAP7 DDX11 IQCA1L SUPV3L1 ATP11C RAB26 HSPA9 AGAP3 ATP13A4 DYNC2H1 DDX60 DNAH2 RNF213 BTAF1 XRCC5 DNAH7 ORC4 ARHGAP5 CCT6A TRAP1 GTPBP2 TSR1 MACF1 DDX20 MTREX | 1.98e-11 | 775 | 230 | 34 | GO:0017111 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ATP7A ATP7B ATRX PSMC1 MCM3 CHD1 DDX11 IQCA1L SUPV3L1 ATP11C HSPA9 ATP13A4 DYNC2H1 DDX60 DNAH2 RNF213 BTAF1 XRCC5 DNAH7 ORC4 CCT6A TRAP1 MACF1 DDX20 MTREX | 5.84e-11 | 441 | 230 | 25 | GO:0016887 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RAB11B ATP7A ATP7B ATRX MTG2 RAB11A PSMC1 MCM3 CHD1 GIMAP7 DDX11 IQCA1L SUPV3L1 ATP11C RAB26 HSPA9 AGAP3 ATP13A4 DYNC2H1 DDX60 DNAH2 RNF213 BTAF1 XRCC5 DNAH7 ORC4 ARHGAP5 CCT6A TRAP1 GTPBP2 TSR1 MACF1 DDX20 MTREX | 1.65e-10 | 839 | 230 | 34 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RAB11B ATP7A ATP7B ATRX MTG2 RAB11A PSMC1 MCM3 CHD1 GIMAP7 DDX11 IQCA1L SUPV3L1 ATP11C RAB26 HSPA9 AGAP3 ATP13A4 DYNC2H1 DDX60 DNAH2 RNF213 BTAF1 XRCC5 DNAH7 ORC4 ARHGAP5 CCT6A TRAP1 GTPBP2 TSR1 MACF1 DDX20 MTREX | 1.71e-10 | 840 | 230 | 34 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RAB11B ATP7A ATP7B ATRX MTG2 RAB11A PSMC1 MCM3 CHD1 GIMAP7 DDX11 IQCA1L SUPV3L1 ATP11C RAB26 HSPA9 AGAP3 ATP13A4 DYNC2H1 DDX60 DNAH2 RNF213 BTAF1 XRCC5 DNAH7 ORC4 ARHGAP5 CCT6A TRAP1 GTPBP2 TSR1 MACF1 DDX20 MTREX | 1.71e-10 | 840 | 230 | 34 | GO:0016818 |
| GeneOntologyMolecularFunction | helicase activity | ATRX MCM3 CHD1 DDX11 SUPV3L1 ANXA1 DDX60 ZNFX1 BTAF1 XRCC5 DDX20 MTREX | 3.07e-07 | 158 | 230 | 12 | GO:0004386 |
| GeneOntologyMolecularFunction | ribose phosphate diphosphokinase activity | 1.48e-05 | 5 | 230 | 3 | GO:0004749 | |
| GeneOntologyMolecularFunction | diphosphotransferase activity | 2.94e-05 | 6 | 230 | 3 | GO:0016778 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.62e-05 | 18 | 230 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.13e-04 | 127 | 230 | 8 | GO:0008094 | |
| GeneOntologyMolecularFunction | P-type divalent copper transporter activity | 1.32e-04 | 2 | 230 | 2 | GO:0043682 | |
| GeneOntologyMolecularFunction | P-type monovalent copper transporter activity | 1.32e-04 | 2 | 230 | 2 | GO:0140581 | |
| GeneOntologyMolecularFunction | magnesium ion binding | PRPS2 PRPSAP1 ERN1 MTG2 TSSK2 ME1 NLRC4 ATP11C CDC42BPB MAST3 PRPS1 | 1.44e-04 | 247 | 230 | 11 | GO:0000287 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERN1 ATRX MCM3 CHD1 DDX11 AGO4 SUPV3L1 ANXA1 DDX60 KHNYN ZNFX1 BTAF1 XRCC5 POLR3B CNOT6L PUS10 PTRH2 DDX20 MTREX | 1.82e-04 | 645 | 230 | 19 | GO:0140640 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.83e-04 | 28 | 230 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 7.36e-04 | 62 | 230 | 5 | GO:0003678 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 7.56e-04 | 36 | 230 | 4 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 7.56e-04 | 36 | 230 | 4 | GO:0015662 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.28e-03 | 70 | 230 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 1.29e-03 | 5 | 230 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.36e-03 | 42 | 230 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | NAD binding | 1.54e-03 | 73 | 230 | 5 | GO:0051287 | |
| GeneOntologyMolecularFunction | transition metal ion transmembrane transporter activity | 1.62e-03 | 44 | 230 | 4 | GO:0046915 | |
| GeneOntologyMolecularFunction | AMP binding | 1.72e-03 | 21 | 230 | 3 | GO:0016208 | |
| GeneOntologyBiologicalProcess | Golgi to plasma membrane protein transport | 1.02e-05 | 45 | 230 | 6 | GO:0043001 | |
| GeneOntologyBiologicalProcess | Golgi to plasma membrane transport | 1.29e-05 | 70 | 230 | 7 | GO:0006893 | |
| GeneOntologyBiologicalProcess | establishment of protein localization to plasma membrane | 2.23e-05 | 76 | 230 | 7 | GO:0061951 | |
| GeneOntologyBiologicalProcess | vesicle-mediated transport to the plasma membrane | 2.42e-05 | 172 | 230 | 10 | GO:0098876 | |
| GeneOntologyBiologicalProcess | 5-phosphoribose 1-diphosphate metabolic process | 2.67e-05 | 6 | 230 | 3 | GO:0046391 | |
| GeneOntologyBiologicalProcess | 5-phosphoribose 1-diphosphate biosynthetic process | 2.67e-05 | 6 | 230 | 3 | GO:0006015 | |
| GeneOntologyBiologicalProcess | transition metal ion transport | 3.96e-05 | 113 | 230 | 8 | GO:0000041 | |
| GeneOntologyBiologicalProcess | post-Golgi vesicle-mediated transport | 5.74e-05 | 119 | 230 | 8 | GO:0006892 | |
| GeneOntologyBiologicalProcess | peptidyl-serine autophosphorylation | 1.09e-04 | 9 | 230 | 3 | GO:0036289 | |
| GeneOntologyBiologicalProcess | negative regulation of protein polyubiquitination | 1.09e-04 | 9 | 230 | 3 | GO:1902915 | |
| GeneOntologyCellularComponent | ribose phosphate diphosphokinase complex | 1.23e-05 | 5 | 226 | 3 | GO:0002189 | |
| MousePheno | abnormal circulating copper level | 7.64e-06 | 4 | 175 | 3 | MP:0006348 | |
| Domain | P-loop_NTPase | TANC2 RAB11B ATRX MTG2 RAB11A PSMC1 MCM3 CHD1 GIMAP7 KIF24 NLRC4 DDX11 MPP4 SUPV3L1 DLG4 KIFC3 RAB26 AGAP3 TPST2 DYNC2H1 DDX60 DNAH2 RNF213 ZNFX1 BTAF1 DNAH7 ORC4 ARHGAP5 GTPBP2 DDX20 MTREX | 3.52e-08 | 848 | 225 | 31 | IPR027417 |
| Domain | - | RAB11B ATRX MTG2 RAB11A PSMC1 MCM3 CHD1 GIMAP7 NLRC4 DDX11 MPP4 SUPV3L1 DLG4 RAB26 AGAP3 TPST2 DYNC2H1 DDX60 DNAH2 RNF213 ZNFX1 BTAF1 DNAH7 ORC4 ARHGAP5 GTPBP2 DDX20 MTREX | 1.00e-07 | 746 | 225 | 28 | 3.40.50.300 |
| Domain | ARM-type_fold | CLTCL1 PSMD1 DOCK5 PIK3C2G RRP12 EIF2B5 ULK4 ARMC8 MYBBP1A ZNFX1 BTAF1 HEATR1 ARMCX5 PPP4R4 RIC8B STAG3 PPP6R3 | 8.15e-07 | 339 | 225 | 17 | IPR016024 |
| Domain | 2-Hacid_dh_C | 6.84e-06 | 4 | 225 | 3 | PF02826 | |
| Domain | D_2_HYDROXYACID_DH_2 | 6.84e-06 | 4 | 225 | 3 | PS00670 | |
| Domain | D_2_HYDROXYACID_DH_3 | 6.84e-06 | 4 | 225 | 3 | PS00671 | |
| Domain | D-isomer_2_OHA_DH_cat_dom | 6.84e-06 | 4 | 225 | 3 | IPR006139 | |
| Domain | D-isomer_DH_CS | 6.84e-06 | 4 | 225 | 3 | IPR029753 | |
| Domain | 2-Hacid_dh | 6.84e-06 | 4 | 225 | 3 | PF00389 | |
| Domain | D_2_HYDROXYACID_DH_1 | 6.84e-06 | 4 | 225 | 3 | PS00065 | |
| Domain | D-isomer_DH_NAD-bd | 1.69e-05 | 5 | 225 | 3 | IPR006140 | |
| Domain | Pribosyltran_N | 1.69e-05 | 5 | 225 | 3 | PF13793 | |
| Domain | Pribosyl_synth | 1.69e-05 | 5 | 225 | 3 | PF14572 | |
| Domain | Rib-P_diPkinase | 1.69e-05 | 5 | 225 | 3 | IPR005946 | |
| Domain | Pribosyltran_N | 1.69e-05 | 5 | 225 | 3 | IPR029099 | |
| Domain | PDZ | 5.38e-05 | 141 | 225 | 9 | PF00595 | |
| Domain | PDZ | 7.84e-05 | 148 | 225 | 9 | SM00228 | |
| Domain | SAM/pointed | 8.66e-05 | 117 | 225 | 8 | IPR013761 | |
| Domain | - | 8.69e-05 | 150 | 225 | 9 | 2.30.42.10 | |
| Domain | PDZ | 9.15e-05 | 151 | 225 | 9 | PS50106 | |
| Domain | PDZ | 9.62e-05 | 152 | 225 | 9 | IPR001478 | |
| Domain | - | 1.20e-04 | 64 | 225 | 6 | 3.40.50.1000 | |
| Domain | P-typ_ATPase_IB | 1.44e-04 | 2 | 225 | 2 | IPR027256 | |
| Domain | HMA_Cu_ion-bd | 1.44e-04 | 2 | 225 | 2 | IPR006122 | |
| Domain | SAM_DOMAIN | 1.51e-04 | 95 | 225 | 7 | PS50105 | |
| Domain | Spectrin | 1.52e-04 | 23 | 225 | 4 | PF00435 | |
| Domain | SAM | 1.72e-04 | 97 | 225 | 7 | IPR001660 | |
| Domain | Ank_3 | 1.94e-04 | 10 | 225 | 3 | PF13606 | |
| Domain | Pribosyltran | 2.65e-04 | 11 | 225 | 3 | PF00156 | |
| Domain | - | 2.98e-04 | 106 | 225 | 7 | 1.10.150.50 | |
| Domain | Helicase_C | 3.15e-04 | 107 | 225 | 7 | PF00271 | |
| Domain | HELICc | 3.15e-04 | 107 | 225 | 7 | SM00490 | |
| Domain | Helicase_C | 3.34e-04 | 108 | 225 | 7 | IPR001650 | |
| Domain | PRibTrfase_dom | 3.50e-04 | 12 | 225 | 3 | IPR000836 | |
| Domain | PRTase-like | 3.50e-04 | 12 | 225 | 3 | IPR029057 | |
| Domain | - | 3.50e-04 | 12 | 225 | 3 | 3.40.50.2020 | |
| Domain | HELICASE_CTER | 3.53e-04 | 109 | 225 | 7 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 3.53e-04 | 109 | 225 | 7 | PS51192 | |
| Domain | - | PSMD1 RRP12 ULK4 ARMC8 BTAF1 HEATR1 ARMCX5 PPP4R4 RIC8B STAG3 | 3.73e-04 | 222 | 225 | 10 | 1.25.10.10 |
| Domain | HAD-like_dom | 3.82e-04 | 79 | 225 | 6 | IPR023214 | |
| Domain | Spectrin_repeat | 3.84e-04 | 29 | 225 | 4 | IPR002017 | |
| Domain | PRib_PP_synth_CS | 4.30e-04 | 3 | 225 | 2 | IPR000842 | |
| Domain | VPS13_N2 | 4.30e-04 | 3 | 225 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 4.30e-04 | 3 | 225 | 2 | IPR031642 | |
| Domain | PRPP_SYNTHASE | 4.30e-04 | 3 | 225 | 2 | PS00114 | |
| Domain | VPS13 | 4.30e-04 | 3 | 225 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 4.30e-04 | 3 | 225 | 2 | PF16910 | |
| Domain | VPS13 | 4.30e-04 | 3 | 225 | 2 | PF16908 | |
| Domain | Heavy-metal-associated_CS | 4.30e-04 | 3 | 225 | 2 | IPR017969 | |
| Domain | ARM-like | PSMD1 RRP12 ULK4 ARMC8 BTAF1 HEATR1 ARMCX5 PPP4R4 RIC8B STAG3 PPP6R3 | 4.51e-04 | 270 | 225 | 11 | IPR011989 |
| Domain | SPEC | 5.66e-04 | 32 | 225 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 5.66e-04 | 32 | 225 | 4 | IPR018159 | |
| Domain | - | 5.66e-04 | 32 | 225 | 4 | 3.40.1110.10 | |
| Domain | - | 5.66e-04 | 32 | 225 | 4 | 2.70.150.10 | |
| Domain | MT | 5.69e-04 | 14 | 225 | 3 | PF12777 | |
| Domain | AAA_8 | 5.69e-04 | 14 | 225 | 3 | PF12780 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.69e-04 | 14 | 225 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 5.69e-04 | 14 | 225 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 5.69e-04 | 14 | 225 | 3 | IPR013602 | |
| Domain | DHC_N2 | 5.69e-04 | 14 | 225 | 3 | PF08393 | |
| Domain | SAM | 6.81e-04 | 88 | 225 | 6 | SM00454 | |
| Domain | DHC_fam | 7.05e-04 | 15 | 225 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 7.05e-04 | 15 | 225 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 7.05e-04 | 15 | 225 | 3 | IPR004273 | |
| Domain | ATPase_P-typ_cyto_domN | 8.01e-04 | 35 | 225 | 4 | IPR023299 | |
| Domain | KASH | 8.53e-04 | 4 | 225 | 2 | PS51049 | |
| Domain | KASH | 8.53e-04 | 4 | 225 | 2 | PF10541 | |
| Domain | VPS13_C | 8.53e-04 | 4 | 225 | 2 | IPR031645 | |
| Domain | HMA_2 | 8.53e-04 | 4 | 225 | 2 | PS50846 | |
| Domain | HMA_1 | 8.53e-04 | 4 | 225 | 2 | PS01047 | |
| Domain | KASH | 8.53e-04 | 4 | 225 | 2 | IPR012315 | |
| Domain | SHR-BD | 8.53e-04 | 4 | 225 | 2 | IPR009543 | |
| Domain | HMA | 8.53e-04 | 4 | 225 | 2 | PF00403 | |
| Domain | KASH | 8.53e-04 | 4 | 225 | 2 | SM01249 | |
| Domain | VPS13_C | 8.53e-04 | 4 | 225 | 2 | PF16909 | |
| Domain | SHR-BD | 8.53e-04 | 4 | 225 | 2 | PF06650 | |
| Domain | - | TANC2 ANKS1B KIDINS220 NFKB1 ANKDD1B AGAP3 ANK1 ANK3 ANKRD62 TNKS2 | 8.82e-04 | 248 | 225 | 10 | 1.25.40.20 |
| Domain | ATPase_P-typ_P_site | 8.93e-04 | 36 | 225 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 8.93e-04 | 36 | 225 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 8.93e-04 | 36 | 225 | 4 | PS00154 | |
| Domain | - | 9.11e-04 | 93 | 225 | 6 | 1.10.533.10 | |
| Domain | ANK | TANC2 ANKS1B KIDINS220 NFKB1 ANKDD1B AGAP3 ANK1 ANK3 ANKRD62 TNKS2 | 9.66e-04 | 251 | 225 | 10 | SM00248 |
| Domain | ATPase_P-typ_transduc_dom_A | 9.92e-04 | 37 | 225 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 9.92e-04 | 37 | 225 | 4 | PF00122 | |
| Domain | ANK_REPEAT | TANC2 ANKS1B KIDINS220 NFKB1 ANKDD1B AGAP3 ANK1 ANK3 ANKRD62 TNKS2 | 1.03e-03 | 253 | 225 | 10 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | TANC2 ANKS1B KIDINS220 NFKB1 ANKDD1B AGAP3 ANK1 ANK3 ANKRD62 TNKS2 | 1.06e-03 | 254 | 225 | 10 | IPR020683 |
| Domain | ANK_REP_REGION | TANC2 ANKS1B KIDINS220 NFKB1 ANKDD1B AGAP3 ANK1 ANK3 ANKRD62 TNKS2 | 1.06e-03 | 254 | 225 | 10 | PS50297 |
| Domain | Death_domain | 1.10e-03 | 38 | 225 | 4 | IPR000488 | |
| Domain | DEATH_DOMAIN | 1.10e-03 | 38 | 225 | 4 | PS50017 | |
| Domain | CH | 1.11e-03 | 65 | 225 | 5 | SM00033 | |
| Domain | NAD(P)-bd_dom | 1.21e-03 | 173 | 225 | 8 | IPR016040 | |
| Domain | GDS_CDC24_CS | 1.21e-03 | 39 | 225 | 4 | IPR001331 | |
| Domain | Ank_2 | 1.22e-03 | 215 | 225 | 9 | PF12796 | |
| Domain | DEATH-like_dom | 1.26e-03 | 99 | 225 | 6 | IPR011029 | |
| Domain | SH3 | 1.26e-03 | 216 | 225 | 9 | PS50002 | |
| Domain | Ankyrin_rpt | TANC2 ANKS1B KIDINS220 NFKB1 ANKDD1B AGAP3 ANK1 ANK3 ANKRD62 TNKS2 | 1.33e-03 | 262 | 225 | 10 | IPR002110 |
| Domain | SAM_1 | 1.37e-03 | 68 | 225 | 5 | PF00536 | |
| Domain | SH3_domain | 1.43e-03 | 220 | 225 | 9 | IPR001452 | |
| Domain | CH | 1.56e-03 | 70 | 225 | 5 | PF00307 | |
| Domain | HEAT_REPEAT | 1.56e-03 | 70 | 225 | 5 | PS50077 | |
| Pubmed | PRPS2 RAB11B CLTCL1 ATRX RAB11A ANKS1B PSMD1 RYR2 DDX11 ACSL3 STRN LMLN SYNE2 PKHD1 ATP11C MCF2L SIPA1L2 HSPA9 MYBBP1A SYNE1 COQ6 DNAH2 CCDC150 HEATR1 PPARA SRBD1 XRCC5 PPP4R4 ATP5MG CCT6A TRAP1 SHANK2 SEC23IP MACF1 IFT122 POFUT1 RIMS2 ZNF292 RPL18A PRPS1 | 1.66e-14 | 1442 | 231 | 40 | 35575683 | |
| Pubmed | PRPSAP1 EMC1 CLTCL1 USE1 PSMC1 PSMD1 MCM3 RRM1 ACSL3 NFKB1 RRP12 SYNE2 EIF2B5 ARMC8 DDX60 RNF213 BTAF1 HEATR1 XRCC5 MRPL4 ATP5MG CCT6A TRAP1 POLR3B CNOT6L FANCI PTRH2 PRKCA CTBP1 DDX20 EXOC2 MTREX VPS53 LRRFIP1 PPP6R3 AHNAK2 PRPS1 | 1.78e-12 | 1440 | 231 | 37 | 30833792 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EMC1 ATRX VPS13C ACOT13 RAB11A PSMC1 PSMD1 MCM3 PFAS CHD1 RPL10A ACSL3 KIDINS220 SUPV3L1 RRP12 EIF2B5 HSPA9 ARMC8 MYBBP1A DYNC2H1 SYNE1 HEATR1 XRCC5 MRPL4 ATP5MG CCT6A TRAP1 RIC8B TSR1 FANCI SEC23IP CTBP2 DDX20 MTREX RPL18A PRPS1 | 5.96e-12 | 1425 | 231 | 36 | 30948266 |
| Pubmed | EMC1 ATP7A ATRX USE1 RAB11A PFAS CHD1 RRM1 RPL10A ACSL3 NEO1 KIDINS220 RRP12 SYNE2 SIPA1L2 HSPA9 FAM184A MYBBP1A ANK3 DYNC2H1 SYNE1 HEATR1 XRCC5 CDC42BPB SNX29 MRPL4 TSR1 P4HA1 TRABD FARP1 PTRH2 MACF1 IFT122 MAST3 PPP6R3 RPL18A | 1.98e-11 | 1487 | 231 | 36 | 33957083 | |
| Pubmed | DCHS2 ATRX ANKS1B PSMC1 IST1 PSMD1 GTF3C4 UBA7 GRHPR NECAB1 SUPV3L1 DLG4 KIFC3 COPS5 HSPA9 ARMC8 AGAP3 ANK3 SYNE1 ZNFX1 CDC42BPB CEP63 ARHGAP5 FAIM POLR3B MICAL2 SEC23IP MACF1 CTBP1 IFT122 TNKS2 LRRFIP1 ZNF292 | 3.28e-11 | 1285 | 231 | 33 | 35914814 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | CLTCL1 PSMD1 RPL10A ACSL3 STRN INTS14 RRP12 MYBBP1A SYNE1 CCDC85C XRCC5 ELP3 CDC42BPB CCT6A TRAP1 P4HA1 FANCI TRABD DDX20 MTREX PPP6R3 RPL18A | 5.13e-11 | 573 | 231 | 22 | 28330616 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PSMC1 PSMD1 MCM3 PFAS CHD1 RRM1 GTF3C4 RPL10A ACSL3 GRHPR SUPV3L1 RRP12 EIF2B5 HSPA9 MYBBP1A ANXA1 HEATR1 SRBD1 XRCC5 ELP3 CCT6A POLR3B MICAL2 FANCI PRKCA MACF1 CTBP2 DDX20 EXOC2 MTREX RIOK2 AHNAK2 RPL18A | 1.25e-10 | 1353 | 231 | 33 | 29467282 |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | PRPS2 TANC2 ATRX MCM3 GTF3C4 TUFT1 DOCK5 ACSL3 STRN NFKB1 EIF2B5 COPS5 ARHGEF6 ARMC8 AGAP3 MYBBP1A ANK3 DYNC2H1 CCDC150 CCDC85C HEATR1 TRAP1 CNOT6L SEC23IP CTBP1 CTBP2 DDX20 IFT122 EXOC2 PACRG VPS53 MAST3 | 2.91e-10 | 1321 | 231 | 32 | 27173435 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | PRPS2 PRPSAP1 EMC1 RAB11A PSMC1 PSMD1 MCM3 PFAS CHD1 RRM1 RPL10A RRP12 SYNE2 HSPA9 MYBBP1A ANXA1 DIDO1 XRCC5 ELP3 ORC4 CCT6A TSR1 PTRH2 MACF1 DDX20 EXOC2 MTREX RIOK2 LRRFIP1 PPP6R3 AHNAK2 RPL18A PRPS1 | 3.90e-10 | 1415 | 231 | 33 | 28515276 |
| Pubmed | EMC1 ATRX RAB11A PSMC1 IST1 CHD1 ARHGEF11 STRN KIDINS220 RRP12 ARMC8 AGAP3 FAM184A SYNE1 DIDO1 E4F1 HEATR1 SRBD1 CDC42BPB ORC4 CCT6A CNOT6L SHANK2 TSR1 P4HA1 FARP1 PTRH2 MACF1 CTBP1 CTBP2 DDX20 EXOC2 MTREX PPP6R3 | 4.08e-10 | 1497 | 231 | 34 | 31527615 | |
| Pubmed | TANC2 ANKS1B PSMC1 ARHGEF11 RPL10A STRN KIDINS220 SRGAP3 DLG4 SIPA1L2 HSPA9 ARMC8 AGAP3 MYBBP1A ANK3 ANXA1 SYNE1 ZNFX1 ELP3 CDC42BPB ATP5MG ARHGAP5 CCT6A SHANK2 MICAL2 FARP1 PRKCA MACF1 CTBP1 SLC4A4 LRRFIP1 RPL18A PRPS1 | 5.19e-10 | 1431 | 231 | 33 | 37142655 | |
| Pubmed | PRPSAP1 RAB11A PSMC1 PSMD1 GTF3C4 ACSL3 COPS9 RRP12 COPS5 HSPA9 RC3H2 MYBBP1A CCDC85C CCT6A TRAP1 TSR1 PTRH2 RIOK2 PPP6R3 SPIN3 | 9.33e-10 | 547 | 231 | 20 | 37267103 | |
| Pubmed | TANC2 ANKS1B MCM3 ARHGEF11 STRN SRGAP3 SYNE2 DLG4 HSPA9 ARMC8 MYBBP1A ANK3 SYNE1 DIDO1 ZNFX1 XRCC5 CDC42BPB SHANK2 FARP1 SEC23IP PRKCA MACF1 CTBP1 CTBP2 SLC4A4 LRRFIP1 | 1.70e-09 | 963 | 231 | 26 | 28671696 | |
| Pubmed | RAB11B ATP7A VPS13C RAB11A MCM3 RYR2 DOCK5 FAT1 NEO1 KIDINS220 HSPA9 AGAP3 MYBBP1A ANK3 RNF213 CDC42BPB DNAH7 CCT6A GTPBP2 SEC23IP CTBP1 RPL18A PRPS1 | 2.84e-09 | 777 | 231 | 23 | 35844135 | |
| Pubmed | TANC2 EMC1 ANKS1B PSMC1 PSMD1 RYR2 ACSL3 STRN NEO1 SRGAP3 DLG4 SIPA1L2 HSPA9 AGAP3 ANK3 ANXA1 ZNFX1 CDC42BPB CCT6A TRAP1 SHANK2 FARP1 PITPNM3 PRKCA MACF1 SLC4A4 LRRFIP1 RPL18A | 3.03e-09 | 1139 | 231 | 28 | 36417873 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ATRX VPS13C PSMD1 ADGRV1 DOCK5 PCYOX1L KIDINS220 LMLN MCF2L COPS5 AGAP3 ANK3 PPFIBP2 CCDC85C RNF213 BTAF1 TTYH3 PPARA XRCC5 CDC42BPB SNX29 PPP4R4 RIC8B SHANK2 GUCY1A1 MICAL2 FARP1 MACF1 CTBP1 CTBP2 IFT122 PACRG | 5.34e-09 | 1489 | 231 | 32 | 28611215 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | RAB11B EMC1 USE1 VPS13C MTG2 PSMC1 PSMD1 RPL10A ACSL3 STRN SUPV3L1 RRP12 SYNE2 RMND1 HSPA9 MYBBP1A SYNE1 RNF213 HEATR1 XRCC5 MRPL4 PIKFYVE ATP5MG CCT6A TRAP1 VPS13D TRABD SEC23IP PTRH2 DDX20 AHNAK2 RPL18A | 5.97e-09 | 1496 | 231 | 32 | 32877691 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | PRPS2 PRPSAP1 EMC1 PSMC1 PSMD1 MCM3 PFAS RRM1 GTF3C4 DDX11 RPL10A ACSL3 COPS5 HSPA9 MYBBP1A BTAF1 XRCC5 ELP3 MRPL4 CCT6A TRAP1 FANCI CTBP1 CTBP2 DDX20 NUB1 PPP6R3 RPL18A PRPS1 | 6.37e-09 | 1257 | 231 | 29 | 37317656 |
| Pubmed | PSMC1 PSMD1 GTF3C4 ACSL3 PCYOX1L INTS14 MOCS3 EIF2B5 COPS5 HSPA9 GNPAT ELP3 TRAP1 POLR3B FANCI SEC23IP EXOC2 MTREX PPP6R3 | 8.36e-09 | 560 | 231 | 19 | 35241646 | |
| Pubmed | EMC1 PSMC1 PSMD1 PFAS ME1 ACSL3 PHKA1 MTMR11 PTPRN NFKB1 RRP12 SYNE2 MYBBP1A ANK3 CCDC85C RNF213 ELP3 CDC42BPB PPP4R4 ARHGAP5 MTMR4 TSR1 P4HA1 FANCI FARP1 PPP6R3 | 9.83e-09 | 1049 | 231 | 26 | 27880917 | |
| Pubmed | PSMC1 DDX11 PHKA1 SYNE2 RC3H2 ANK3 XRCC5 ELP3 SNX29 CEP63 PIKFYVE FARP1 VPS53 | 1.59e-08 | 251 | 231 | 13 | 29778605 | |
| Pubmed | PSMD1 PFAS CHD1 RPL10A ACSL3 RRP12 SYNE2 HSPA9 MYBBP1A ANXA1 DIDO1 HEATR1 XRCC5 TSR1 FANCI MACF1 DDX20 MTREX PPP6R3 RPL18A | 1.84e-08 | 653 | 231 | 20 | 22586326 | |
| Pubmed | RAB11B ATP7A ATP7B ERN1 USE1 RAB11A PSMD1 RRM1 ACSL3 FAT1 NEO1 KIDINS220 ATP11C COPS5 HSPA9 PIKFYVE ATP5MG TRAP1 SEC23IP PTRH2 CTBP2 POFUT1 SLC4A4 RPL18A | 2.75e-08 | 952 | 231 | 24 | 38569033 | |
| Pubmed | PRPSAP1 EMC1 MTG2 PFAS GTF3C4 ACSL3 KIDINS220 RRP12 SIPA1L2 DYNC2H1 HEATR1 TRAP1 VPS13D FANCI TRABD SEC23IP EXOC2 VPS53 PPP6R3 | 2.93e-08 | 606 | 231 | 19 | 36538041 | |
| Pubmed | USE1 KDM5C GTF3C4 MYSM1 FAT1 NFKB1 RC3H2 ANK1 CDC42BPB TRAP1 FARP1 PTRH2 MACF1 AHNAK2 | 5.85e-08 | 332 | 231 | 14 | 37433992 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | PRPS2 RAB11B PSMC1 PSMD1 MCM3 PFAS ME1 RPL10A PHKA1 PCYOX1L RRP12 HSPA9 MYBBP1A ANK3 ANXA1 KHNYN XRCC5 CCT6A TRAP1 TSR1 P4HA1 FANCI MACF1 DDX20 RPL18A PRPS1 | 6.03e-08 | 1149 | 231 | 26 | 35446349 |
| Pubmed | RAB11A PSMC1 PSMD1 MCM3 RRM1 RPL10A HSPA9 AGAP3 MYBBP1A HEATR1 XRCC5 CCT6A TRAP1 FANCI SEC23IP DDX20 MTREX PPP6R3 RPL18A | 6.56e-08 | 638 | 231 | 19 | 33239621 | |
| Pubmed | VPS13C ADGRV1 FAT2 HSPA9 SYNE1 ZNFX1 HMCN1 FANCI MACF1 WDSUB1 | 8.10e-08 | 152 | 231 | 10 | 34299191 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TANC2 CLTCL1 MTG2 PFAS ARHGEF11 DYSF FAT1 RRP12 ULK4 KIFC3 MCF2L SIPA1L2 AGAP3 TPST2 KHNYN AOC2 BTAF1 TTYH3 PPARA CDC42BPB PIKFYVE SHANK2 FANCI POFUT1 AHNAK2 | 1.11e-07 | 1105 | 231 | 25 | 35748872 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | RAB11B CLTCL1 RAB11A PSMD1 MCM3 ME1 GTF3C4 RPL10A GRHPR MYBBP1A ANK3 DYNC2H1 ANXA1 SYNE1 COQ6 XRCC5 CCT6A TRAP1 MACF1 AHNAK2 PRPS1 | 1.26e-07 | 807 | 231 | 21 | 30575818 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RAB11B PSMC1 IST1 PFAS RRM1 RPL10A ACSL3 GRHPR SUPV3L1 NFKB1 RRP12 SYNE2 HSPA9 MYBBP1A ANXA1 RBP1 RNF213 TTYH3 XRCC5 MRPL4 CCT6A P4HA1 PTRH2 PRKCA DDX20 LRRFIP1 AHNAK2 RPL18A | 1.42e-07 | 1367 | 231 | 28 | 32687490 |
| Pubmed | ATRX PSMC1 PSMD1 MCM3 CHD1 RPL10A HSPA9 AGAP3 ANXA1 XRCC5 CCT6A TSR1 TRABD MACF1 PPP6R3 AHNAK2 RPL18A | 1.44e-07 | 538 | 231 | 17 | 28524877 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | IST1 RPL10A ACSL3 SRGAP3 RRP12 SYNE2 MYBBP1A ANXA1 HEATR1 CDC42BPB GRIP1 FARP1 MACF1 CTBP1 PPP6R3 PRPS1 | 2.71e-07 | 498 | 231 | 16 | 36634849 |
| Pubmed | 2.89e-07 | 3 | 231 | 3 | 9366267 | ||
| Pubmed | 2.89e-07 | 3 | 231 | 3 | 25816608 | ||
| Pubmed | CLTCL1 ATP7A ATP7B PSMC1 PSMD1 MCM3 RPL10A ACSL3 PCYOX1L KIDINS220 AGO4 GNPAT MYBBP1A RNF213 HEATR1 XRCC5 TRAP1 P4HA1 FANCI PTRH2 DDX20 IFT122 POFUT1 EXOC2 RPL18A | 3.11e-07 | 1168 | 231 | 25 | 19946888 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | VPS13C PSMC1 IST1 MCM3 ARHGEF11 STRN NFKB1 SIPA1L2 HSPA9 FAM184A ZNF507 CCDC85C CASP9 DNAH7 GRIP1 ARHGAP5 CCT6A TSR1 FARP1 PRKCA PPP6R3 | 3.13e-07 | 853 | 231 | 21 | 28718761 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ATRX IST1 PFAS CHD1 GTF3C4 RPL10A RRP12 SIPA1L2 HSPA9 MYBBP1A CCDC85C DIDO1 BTAF1 HEATR1 XRCC5 SNX29 TRAP1 SEC23IP MACF1 PPP6R3 AHNAK2 RPL18A | 3.42e-07 | 934 | 231 | 22 | 33916271 |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | EMC1 USE1 PSMC1 PSMD1 ACSL3 KIDINS220 RRP12 EIF2B5 MYBBP1A DYNC2H1 DNAH2 BTAF1 HEATR1 P4HA1 FANCI TRABD SEC23IP PTRH2 DDX20 POFUT1 VPS53 PPP6R3 | 3.94e-07 | 942 | 231 | 22 | 31073040 |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | ATRX KDM5C PSMC1 MCM3 RRM1 GTF3C4 RNF213 DIDO1 XRCC5 CCT6A TSR1 P4HA1 AHNAK2 | 4.08e-07 | 332 | 231 | 13 | 32786267 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PRPS2 PRPSAP1 PSMC1 IST1 PSMD1 MCM3 PFAS RRM1 ME1 MEA1 GTF3C4 COPS5 HSPA9 XRCC5 ELP3 CCT6A TRAP1 ATG3 TSR1 FANCI SEC23IP MACF1 CTBP2 LRRFIP1 PPP6R3 AHNAK2 RPL18A PRPS1 | 4.97e-07 | 1455 | 231 | 28 | 22863883 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | PRPSAP1 EMC1 ATRX RAB11A PSMC1 PSMD1 MCM3 PFAS CHD1 STRN RRP12 EIF2B5 PYGM KHK MYBBP1A ANXA1 HEATR1 CDC42BPB ATP5MG CNOT6L ATG3 TSR1 FANCI DDX20 MTREX RPL18A | 5.09e-07 | 1284 | 231 | 26 | 17353931 |
| Pubmed | DHRS4L1 ANKS1B PSMC1 RPL10A PYGM DLG4 ANK3 FARP1 PRKCA LRRFIP1 RPL18A | 5.21e-07 | 233 | 231 | 11 | 29518331 | |
| Pubmed | Haploinsufficiency in the ANKS1B gene encoding AIDA-1 leads to a neurodevelopmental syndrome. | 6.03e-07 | 11 | 231 | 4 | 31388001 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | PRPS2 PSMC1 MCM3 CHD1 RPL10A RRP12 HSPA9 MYBBP1A ANK1 DIDO1 HEATR1 XRCC5 MRPL4 ATP5MG ORC4 CCT6A TRAP1 TSR1 P4HA1 CTBP1 CTBP2 DDX20 MTREX RIOK2 RPL18A PRPS1 | 8.30e-07 | 1318 | 231 | 26 | 30463901 |
| Pubmed | Genomic organization of the mottled gene, the mouse homologue of the human Menkes disease gene. | 1.15e-06 | 4 | 231 | 3 | 8921375 | |
| Pubmed | TANC2 PFAS MYSM1 FAT2 SEC16B DYNC2H1 ANKRD62 RNF213 TTYH3 CDC42BPB PPP4R4 PIKFYVE VPS13D MACF1 MAST3 | 1.27e-06 | 493 | 231 | 15 | 15368895 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | DCHS2 KDM5C ARHGEF11 DYSF ME1 GTF3C4 RRP12 RMND1 COPS5 ANK1 ANK3 CASP9 VPS13D P4HA1 ZNF292 | 1.40e-06 | 497 | 231 | 15 | 36774506 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RAB11B EMC1 PSMC1 PSMD1 MCM3 CHD1 RPL10A ACSL3 RRP12 SYNE2 HSPA9 MYBBP1A ANXA1 SYNE1 BTAF1 HEATR1 XRCC5 CCT6A TRAP1 PRKCA MACF1 MTREX | 1.56e-06 | 1024 | 231 | 22 | 24711643 |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | PRPSAP1 GTF3C4 RPL10A HSPA9 MYBBP1A E4F1 SRBD1 XRCC5 CCT6A TSR1 MTREX SPIN3 | 1.58e-06 | 316 | 231 | 12 | 31665637 |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | PRPS2 PRPSAP1 PSMC1 PSMD1 GTF3C4 ACSL3 RRP12 COPS5 HSPA9 GNPAT MYBBP1A ANXA1 HEATR1 FANCI MTREX PPP6R3 | 1.63e-06 | 571 | 231 | 16 | 37167062 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | PRPS2 TANC2 EMC1 ATP7A USE1 VPS13C PSMC1 GNPAT PPFIBP2 SYNE1 CASQ2 BTAF1 TTYH3 ELP3 CDC42BPB SHANK2 SEC23IP MACF1 | 1.79e-06 | 719 | 231 | 18 | 35337019 |
| Pubmed | ATRX RAB11A PSMC1 PSMD1 MCM3 RPL10A RRP12 PYGM HSPA9 MYBBP1A ANXA1 DIDO1 HEATR1 XRCC5 FANCI MTREX RPL18A | 2.03e-06 | 652 | 231 | 17 | 31180492 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | TANC2 ATRX PSMC1 PSMD1 DOCK5 SUPV3L1 COPS5 MYBBP1A BTAF1 ORC4 CCT6A TRAP1 FANCI MACF1 EXOC2 MTREX | 2.08e-06 | 582 | 231 | 16 | 20467437 |
| Pubmed | ACOT13 DHRS4L1 PSMC1 RYR2 CFAP54 PYGM HSPA9 ANK3 COQ6 CASQ2 ATP5MG TRAP1 | 2.55e-06 | 331 | 231 | 12 | 29199018 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | PRPS2 CYBRD1 ATP7B DOCK5 FAT1 NEO1 ATP11C RMND1 HSPA9 GNPAT DYNC2H1 COQ6 RNF213 BTAF1 TTYH3 PPIC ORC4 FANCI SEC23IP PTRH2 MACF1 SLC4A4 | 2.77e-06 | 1061 | 231 | 22 | 33845483 |
| Pubmed | Inactivation of the microRNA-183/96/182 cluster results in syndromic retinal degeneration. | 2.97e-06 | 225 | 231 | 10 | 23341629 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | RPL10A SYNE2 GNPAT RC3H2 DYNC2H1 ANXA1 TSR1 CTBP1 CTBP2 DDX20 IFT122 TNKS2 ZNF292 | 3.05e-06 | 398 | 231 | 13 | 35016035 |
| Pubmed | 3.13e-06 | 177 | 231 | 9 | 26206133 | ||
| Pubmed | PSMC1 PSMD1 MCM3 GTF3C4 RPL10A RRP12 COPS5 HSPA9 ARMC8 MYBBP1A XRCC5 ELP3 MRPL4 ORC4 CCT6A TRAP1 TSR1 PTRH2 CTBP1 CTBP2 MTREX RIOK2 PPP6R3 RPL18A PRPS1 | 3.43e-06 | 1335 | 231 | 25 | 29229926 | |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | CYBRD1 VPS13C IST1 ADGRV1 DYSF FAT1 GRHPR PKHD1 KHK KIFC3 BBOX1 AMN DYNC2H1 ANXA1 AOX1 TTYH3 CDC42BPB CCT6A VPS13D PRKCA SLC4A4 | 4.95e-06 | 1016 | 231 | 21 | 19056867 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ATRX KDM5C PSMD1 MCM3 GTF3C4 ACSL3 RRP12 EIF2B5 ARHGEF6 SEC16B MYBBP1A ZNF507 DIDO1 BTAF1 DDX20 EXOC2 LRRFIP1 PPP6R3 | 4.96e-06 | 774 | 231 | 18 | 15302935 |
| Pubmed | STUB1 is targeted by the SUMO-interacting motif of EBNA1 to maintain Epstein-Barr Virus latency. | 6.07e-06 | 192 | 231 | 9 | 32176739 | |
| Pubmed | VPS13C ANKS1B ADGRV1 ACSL3 SRGAP3 DLG4 SIPA1L2 AGAP3 ELP3 CDC42BPB GRIP1 FARP1 MACF1 | 7.02e-06 | 430 | 231 | 13 | 32581705 | |
| Pubmed | ACOT13 PSMC1 PSMD1 RRM1 ACSL3 GRHPR HSPA9 XRCC5 ATP5MG CCT6A TRAP1 FANCI TRABD SEC23IP CTBP1 CTBP2 PPP6R3 ZNF292 PRPS1 | 7.49e-06 | 878 | 231 | 19 | 37223481 | |
| Pubmed | EMC1 ATRX PFAS DOCK5 SUPV3L1 EIF2B5 GNPAT RC3H2 DIDO1 ZNFX1 BTAF1 GTPBP2 TSR1 IFT122 MTREX RIOK2 | 8.38e-06 | 650 | 231 | 16 | 38777146 | |
| Pubmed | PSMC1 PSMD1 MCM3 RRM1 GTF3C4 RPL10A HSPA9 MYBBP1A BTAF1 XRCC5 MRPL4 CCT6A TSR1 PTRH2 CTBP2 DDX20 MAPK4 MTREX PPP6R3 RPL18A | 8.82e-06 | 971 | 231 | 20 | 33306668 | |
| Pubmed | EMC1 PSMD1 MCM3 RRM1 ACSL3 COPS5 HSPA9 BTAF1 XRCC5 ELP3 CCT6A ATG3 TSR1 NUB1 MTREX PRPS1 | 8.87e-06 | 653 | 231 | 16 | 33742100 | |
| Pubmed | 9.93e-06 | 7 | 231 | 3 | 16059920 | ||
| Pubmed | Direct interaction of GluRdelta2 with Shank scaffold proteins in cerebellar Purkinje cells. | 9.93e-06 | 7 | 231 | 3 | 15207857 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | VPS13C PSMC1 GIMAP7 MAGEB6 DOCK5 GRHPR SRGAP3 DENND4B PKHD1 ANK1 HSPBAP1 DNAH2 RNF213 XRCC5 ARHGAP5 P4HA1 PITPNM3 | 9.98e-06 | 736 | 231 | 17 | 29676528 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ATRX KDM5C MCM3 PFAS DDX11 STRN SIPA1L2 DYNC2H1 ZNF507 PIKFYVE MACF1 CTBP2 DDX20 MTREX PPP6R3 | 1.06e-05 | 588 | 231 | 15 | 38580884 |
| Pubmed | ATRX PSMD1 RYR2 STRN MTMR11 COPS5 ANK3 CPXM2 E4F1 GRIP1 ARHGAP5 MTMR4 MACF1 CTBP2 TNKS2 | 1.13e-05 | 591 | 231 | 15 | 15231748 | |
| Pubmed | Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics. | PSMD1 MCM3 RPL10A RRP12 HSPA9 MYBBP1A XRCC5 MRPL4 CCT6A TSR1 MTREX RPL18A | 1.14e-05 | 384 | 231 | 12 | 31059266 |
| Pubmed | EMC1 USE1 PSMC1 PSMD1 MCM3 PFAS RRM1 EIF2B5 COPS5 GNPAT CEP63 POLR3B MTREX | 1.17e-05 | 451 | 231 | 13 | 30033366 | |
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | MTG2 PFAS LSM5 ACSL3 RRP12 HSPA9 MYBBP1A HEATR1 XRCC5 MRPL4 CCT6A VPS13D ATG3 | 1.25e-05 | 454 | 231 | 13 | 33226137 |
| Pubmed | TANC2 MCM3 CHD1 ARHGEF11 DOCK5 SRGAP3 MCF2L ARHGEF6 AGAP3 ANXA1 HEATR1 MRPL4 ARHGAP5 FANCI FARP1 CTBP2 TNKS2 PPP6R3 SPIN3 | 1.35e-05 | 916 | 231 | 19 | 32203420 | |
| Pubmed | VPS13C PSMC1 PFAS DOCK5 ACSL3 SYNE2 ULK4 RC3H2 DYNC2H1 SYNE1 DNAH2 DIDO1 HEATR1 CCT6A TRABD RIMS2 STAG3 | 1.36e-05 | 754 | 231 | 17 | 35906200 | |
| Pubmed | 1.50e-05 | 215 | 231 | 9 | 30462309 | ||
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | 1.68e-05 | 218 | 231 | 9 | 33378226 | |
| Pubmed | Defining the Protein-Protein Interaction Network of the Human Protein Tyrosine Phosphatase Family. | CLTCL1 RAB11A PHKA1 PTPRN ARMC8 TTYH3 HEATR1 ELP3 CDC42BPB MRPL4 ORC4 MTMR4 PTRH2 CTBP1 CTBP2 DDX20 MAPK4 RPL18A PRPS1 | 1.69e-05 | 931 | 231 | 19 | 27432908 |
| Pubmed | A conserved acetylation switch enables pharmacological control of tubby-like protein stability. | 2.01e-05 | 223 | 231 | 9 | 33187986 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 2.07e-05 | 281 | 231 | 10 | 28706196 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TANC2 EMC1 TSSK2 SYNE2 SIPA1L2 AGAP3 HIPK4 CCDC85C DNAH7 PPP4R4 GRIP1 VPS13D MTMR4 MACF1 NUB1 MAPK4 MTREX AHNAK2 | 2.07e-05 | 861 | 231 | 18 | 36931259 |
| Pubmed | 2.36e-05 | 9 | 231 | 3 | 20877300 | ||
| Pubmed | ATP7A PSMC1 PSMD1 MCM3 RRM1 RPL10A KIDINS220 HSPA9 MYBBP1A ANK3 XRCC5 GRIP1 CCT6A FANCI SEC23IP MACF1 | 2.38e-05 | 708 | 231 | 16 | 39231216 | |
| Pubmed | 2.49e-05 | 128 | 231 | 7 | 30995482 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | RAB11A PSMC1 PSMD1 MCM3 RPL10A ACSL3 RRP12 HSPA9 MYBBP1A SYNE1 HEATR1 XRCC5 CCT6A MTREX RPL18A SPIN3 | 2.64e-05 | 714 | 231 | 16 | 28302793 |
| Pubmed | Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. | PRPS2 PRPSAP1 EMC1 IST1 PSMD1 PFAS RRM1 ACSL3 KIDINS220 ANXA1 AHNAK2 PRPS1 | 2.89e-05 | 422 | 231 | 12 | 27342126 |
| Pubmed | PSMC1 PSMD1 MCM3 RPL10A HSPA9 MYBBP1A ANXA1 XRCC5 CCT6A SEC23IP LRRFIP1 PPP6R3 RPL18A | 3.01e-05 | 494 | 231 | 13 | 26831064 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | EMC1 PSMC1 PSMD1 PFAS CHD1 RPL10A ACSL3 KIDINS220 DLG4 RMND1 SIPA1L2 ARMC8 HEATR1 ELP3 MTMR4 FANCI PTRH2 PPP6R3 PRPS1 | 3.13e-05 | 974 | 231 | 19 | 28675297 |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 3.18e-05 | 182 | 231 | 8 | 30711629 | |
| Pubmed | PSMD1 DYSF NEO1 SYNE2 PYGM HSPA9 SYNE1 PPARA CDC42BPB CCT6A P4HA1 MACF1 TNKS2 | 3.20e-05 | 497 | 231 | 13 | 23414517 | |
| Pubmed | RAB11B CLTCL1 RAB11A PSMC1 PSMD1 CHD1 RRM1 LSM5 RPL10A HSPA9 MYBBP1A XRCC5 DNAH7 MRPL4 ATP5MG CCT6A TRAP1 TSR1 MACF1 MTREX RPL18A | 3.24e-05 | 1153 | 231 | 21 | 29845934 | |
| Pubmed | 3.35e-05 | 10 | 231 | 3 | 20547759 | ||
| Pubmed | KDM5C PSMD1 MCM3 RRP12 ARHGEF6 AGAP3 MYBBP1A DIDO1 FANCI PRKCA DDX20 LRRFIP1 PPP6R3 | 3.62e-05 | 503 | 231 | 13 | 16964243 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | MCM3 CHD1 RPL10A RRP12 HSPA9 MYBBP1A ANXA1 DIDO1 HEATR1 SRBD1 XRCC5 MRPL4 CCT6A TRAP1 TSR1 FANCI CTBP2 MTREX RPL18A | 3.84e-05 | 989 | 231 | 19 | 36424410 |
| Pubmed | 3.86e-05 | 187 | 231 | 8 | 26460568 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | EMC1 MCM3 RPL10A KIDINS220 RRP12 SIPA1L2 ARHGEF6 MYBBP1A SYNE1 DIDO1 XRCC5 MRPL4 CCT6A TSR1 P4HA1 FARP1 MACF1 CTBP1 ZNF292 SPIN3 | 4.10e-05 | 1082 | 231 | 20 | 38697112 |
| Pubmed | ZFP36L2 is a cell cycle-regulated CCCH protein necessary for DNA lesion-induced S-phase arrest. | 4.16e-05 | 189 | 231 | 8 | 29449217 | |
| Interaction | CIT interactions | CLTCL1 MCM3 PFAS CHD1 ADGRV1 RRM1 GTF3C4 RPL10A ACSL3 RRP12 SYNE2 DLG4 CACNA1I ARHGEF6 MYBBP1A DYNC2H1 ANXA1 SYNE1 DDX60 RNF213 DIDO1 HEATR1 SRBD1 XRCC5 ELP3 CCT6A TRAP1 MTMR4 TSR1 P4HA1 FANCI PTRH2 MACF1 DDX20 MTREX STAG3 AHNAK2 RPL18A SPIN3 | 4.06e-07 | 1450 | 229 | 39 | int:CIT |
| Interaction | DCAF11 interactions | VPS13C PSMD1 PFAS COPS9 COPS5 GNPAT ELP3 GRIP1 CCT6A LPIN2 CTBP1 | 4.50e-07 | 136 | 229 | 11 | int:DCAF11 |
| Interaction | DSCAM interactions | ATRX IST1 SUPV3L1 DLG4 KIFC3 COPS5 SYNE1 CEP63 POLR3B MACF1 IFT122 | 4.30e-06 | 171 | 229 | 11 | int:DSCAM |
| Interaction | FBXL6 interactions | PRPSAP1 RAB11A PSMC1 PSMD1 GTF3C4 ACSL3 COPS9 RRP12 COPS5 HSPA9 RC3H2 MYBBP1A CCDC85C CCT6A TRAP1 TSR1 PTRH2 RIOK2 PPP6R3 SPIN3 | 1.21e-05 | 583 | 229 | 20 | int:FBXL6 |
| Interaction | GSK3B interactions | PRPS2 PSMC1 PSMD1 MCM3 PFAS RRM1 ARHGEF11 ACSL3 KIDINS220 NFKB1 EIF2B5 SIPA1L2 COPS5 HSPA9 RC3H2 ANXA1 SNX29 CCT6A TRAP1 VPS13D PRKCA MACF1 DDX20 NUB1 PPP6R3 | 1.97e-05 | 868 | 229 | 25 | int:GSK3B |
| Interaction | AGAP2 interactions | ANKS1B STRN SRGAP3 DLG4 ANK3 SYNE1 GRIP1 SHANK2 PRKCA MACF1 RIMS2 | 2.98e-05 | 210 | 229 | 11 | int:AGAP2 |
| Interaction | CLEC16A interactions | PRPSAP1 EMC1 MTG2 RAB11A PFAS GTF3C4 ACSL3 KIDINS220 RRP12 SIPA1L2 DYNC2H1 HEATR1 TRAP1 VPS13D FANCI TRABD SEC23IP EXOC2 VPS53 PPP6R3 | 3.58e-05 | 629 | 229 | 20 | int:CLEC16A |
| GeneFamily | Ankyrin repeat domain containing | TANC2 ANKS1B ANKRD18B KIDINS220 NFKB1 ANKDD1B AGAP3 ANK1 ANK3 ANKRD62 SHANK2 TNKS2 | 1.05e-06 | 242 | 153 | 12 | 403 |
| GeneFamily | PDZ domain containing | 5.89e-06 | 152 | 153 | 9 | 1220 | |
| GeneFamily | Sterile alpha motif domain containing | 9.69e-06 | 88 | 153 | 7 | 760 | |
| GeneFamily | ATPase copper transporting | 7.11e-05 | 2 | 153 | 2 | 1212 | |
| GeneFamily | X-linked mental retardation|RNA helicases | 9.33e-05 | 11 | 153 | 3 | 1168 | |
| GeneFamily | Cadherin related | 3.70e-04 | 17 | 153 | 3 | 24 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 4.22e-04 | 4 | 153 | 2 | 1252 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.37e-03 | 66 | 153 | 4 | 722 | |
| GeneFamily | Ubiquitin like modifier activating enzymes | 3.06e-03 | 10 | 153 | 2 | 100 | |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | ACOT13 TSSK2 CHD1 DYSF ME1 GRHPR LMLN RMND1 HSPA9 ARHGEF6 GNPAT CASP9 DIDO1 FAIM MTMR4 TRABD LPIN2 PTRH2 PRKCA IFT122 PRPS1 | 3.02e-07 | 646 | 230 | 21 | M2419 |
| Coexpression | WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D | ACOT13 TSSK2 CHD1 DYSF ME1 GRHPR LMLN RMND1 HSPA9 ARHGEF6 GNPAT CASP9 DIDO1 FAIM MTMR4 TRABD LPIN2 PTRH2 PRKCA IFT122 PRPS1 | 6.15e-07 | 675 | 230 | 21 | MM1073 |
| Coexpression | GSE14350_TREG_VS_TEFF_UP | ATP7A MTG2 MYSM1 KIDINS220 SYNE1 ZNF507 RNF213 ZNFX1 ARHGAP5 RIC8B GUCY1A1 | 1.62e-06 | 199 | 230 | 11 | M3417 |
| Coexpression | WU_APOPTOSIS_BY_CDKN1A_VIA_TP53 | 6.96e-06 | 53 | 230 | 6 | M10169 | |
| Coexpression | DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP | 9.77e-06 | 155 | 230 | 9 | M34032 | |
| Coexpression | GSE3982_DC_VS_TH2_DN | RRM1 RYR2 SYNE2 RMND1 ARHGEF6 E4F1 XRCC5 ARHGAP5 MICAL2 FANCI | 1.12e-05 | 199 | 230 | 10 | M5486 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | 2.77e-05 | 221 | 230 | 10 | M39222 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | MCM3 PFAS RRM1 RPL10A ACSL3 PIK3C2G COPS5 MYBBP1A HEATR1 XRCC5 ORC4 CCT6A TRAP1 TSR1 FANCI SEC23IP RPL18A | 3.19e-05 | 612 | 230 | 17 | M4772 |
| Coexpression | LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3 | 3.36e-05 | 181 | 230 | 9 | M39225 | |
| Coexpression | PARENT_MTOR_SIGNALING_UP | USE1 VPS13C BCHE GRHPR SYNE2 EIF2B5 SYNE1 COQ6 CASP9 PPARA VPS13D RIC8B FARP1 CTBP2 IFT122 SLC4A4 | 4.54e-05 | 567 | 230 | 16 | M16909 |
| Coexpression | GSE3982_NEUTROPHIL_VS_BASOPHIL_UP | 6.23e-05 | 196 | 230 | 9 | M5524 | |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | 6.38e-05 | 244 | 230 | 10 | M40312 | |
| Coexpression | LEE_BMP2_TARGETS_DN | MCM3 PFAS CHD1 RRM1 ME1 SUPV3L1 RRP12 HSPA9 MYBBP1A ANKRD62 BTAF1 HEATR1 ORC4 FAIM CCT6A TSR1 SEC23IP PTRH2 DDX20 MTREX PRPS1 | 6.91e-05 | 922 | 230 | 21 | MM1068 |
| Coexpression | GSE27786_LIN_NEG_VS_MONO_MAC_UP | 7.28e-05 | 200 | 230 | 9 | M4796 | |
| Coexpression | CAFFAREL_RESPONSE_TO_THC_8HR_3_DN | 7.65e-05 | 10 | 230 | 3 | M14648 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | TANC2 ANKS1B ADGRV1 ULK4 KIFC3 ANK1 DNAH2 PPARA SNX29 SHANK2 P4HA1 SLC4A4 RIMS2 | 8.85e-05 | 417 | 230 | 13 | M39224 |
| Coexpression | BILD_MYC_ONCOGENIC_SIGNATURE | PCYOX1L MTMR11 SUPV3L1 SLITRK6 MYBBP1A KHNYN RNF213 FARP1 PTRH2 | 1.02e-04 | 209 | 230 | 9 | M2069 |
| Coexpression | GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_DN | 1.15e-04 | 124 | 230 | 7 | M470 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | PTH2R SYNE2 PKHD1 KIFC3 MCF2L ANK3 AOX1 TTYH3 PPARA SNX29 FARP1 SLC4A4 | 3.52e-10 | 191 | 229 | 12 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | PTH2R SYNE2 PKHD1 KIFC3 MCF2L ANK3 AOX1 TTYH3 PPARA SNX29 FARP1 SLC4A4 | 3.52e-10 | 191 | 229 | 12 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | PTH2R FAT1 PKHD1 KIFC3 ANK3 PPARA DNAH7 SNX29 GRIP1 SHANK2 FARP1 SLC4A4 | 3.96e-10 | 193 | 229 | 12 | 3866667dd221612589ae50f5c52f73a183a49ce6 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | PTH2R FAT1 SRGAP3 PKHD1 KIFC3 ANK3 DNAH7 SNX29 GRIP1 SHANK2 FARP1 PACRG | 4.21e-10 | 194 | 229 | 12 | 93c68c31e39fa44c1d05d7d4997f4f086da4e738 |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | PTH2R FAT1 SYNE2 PKHD1 BBOX1 AOX1 DNAH7 GRIP1 SHANK2 FARP1 RIMS2 | 3.08e-09 | 183 | 229 | 11 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | CHD1 NFKB1 RRP12 SYNE2 FAM184A ANK3 RNF213 BTAF1 CNOT6L PRKCA MACF1 | 5.10e-09 | 192 | 229 | 11 | 47646d7e4990be85072987f92bf18d52f8da752e |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ADGRV1 ANKRD18B CFAP54 SRGAP3 FAM184A ANK3 DYNC2H1 RBP1 DNAH2 DNAH7 AHNAK2 | 5.38e-09 | 193 | 229 | 11 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | PTH2R PKHD1 KIFC3 ANK3 PPARA DNAH7 SNX29 GRIP1 SHANK2 FARP1 SLC4A4 | 5.38e-09 | 193 | 229 | 11 | 82e8a4c40299ffcdfd5a0da711bb9de6fb8a2eaa |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | PTH2R FAT1 PKHD1 KIFC3 ANK3 PPARA DNAH7 SNX29 GRIP1 SHANK2 FARP1 | 5.68e-09 | 194 | 229 | 11 | 5eaaa81f4b2535f983c424aaef00077089526a5c |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | PTH2R FAT1 SYNE2 PKHD1 KIFC3 ANK3 SNX29 GRIP1 SHANK2 FARP1 PACRG | 5.68e-09 | 194 | 229 | 11 | 7002937e8903e037332a215d00fbc7c7843b33f2 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | PTH2R SRGAP3 PKHD1 KIFC3 ANK3 PPARA DNAH7 SNX29 GRIP1 SHANK2 FARP1 | 6.32e-09 | 196 | 229 | 11 | eea66711a16134f86e6c533a5a837ff2e0d7ca7f |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | PTH2R FAT1 SRGAP3 PKHD1 KIFC3 ANK3 DNAH7 SNX29 GRIP1 SHANK2 FARP1 | 6.32e-09 | 196 | 229 | 11 | 6ce74aa3f0ce3ca284b67e5a4660ffd2cc9611e0 |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | TANC2 SYNE2 CACNA1I ANK3 SYNE1 ZNF507 RNF213 PCSK7 OR2A25 SLC4A4 ZNF292 | 6.66e-09 | 197 | 229 | 11 | e4331969bd911d1ebb5453f40a7057297b5389b4 |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | CFAP54 LMLN SYNE2 ULK4 LMNTD1 FAM184A DYNC2H1 SYNE1 DNAH2 DNAH7 SHANK2 | 6.66e-09 | 197 | 229 | 11 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | ATRX VPS13C CHD1 SYNE2 DDX60 RNF213 BTAF1 MACF1 NUB1 TRIM44 ZNF292 | 7.80e-09 | 200 | 229 | 11 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | COVID-19-kidney-Epi_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | DCHS2 PTH2R FAT1 CFAP54 SYNE2 PKHD1 DNAH7 GRIP1 SHANK2 FARP1 | 3.09e-08 | 178 | 229 | 10 | 544379f5a6145429762258d426b876bb36c112f5 |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.44e-08 | 180 | 229 | 10 | 358923e4228035a3e90e2957392089219e90dcd7 | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.44e-08 | 180 | 229 | 10 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADGRV1 RYR2 COL24A1 FAT1 PIK3C2G PKHD1 ATP13A4 ANK1 HMCN1 SLC4A4 | 4.23e-08 | 184 | 229 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADGRV1 RYR2 COL24A1 FAT1 PIK3C2G PKHD1 ATP13A4 ANK1 HMCN1 SLC4A4 | 4.23e-08 | 184 | 229 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADGRV1 RYR2 COL24A1 FAT1 PIK3C2G PKHD1 ATP13A4 ANK1 HMCN1 SLC4A4 | 4.23e-08 | 184 | 229 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.69e-08 | 186 | 229 | 10 | 5784d255e9ca449d375d81938d0fbbd8a7eb44f6 | |
| ToppCell | T_cells-ISG-high_CD4+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | GIMAP7 UBA7 SYNE2 FAM184A ANK3 DDX60 RNF213 ZNFX1 LPIN2 NUB1 | 5.18e-08 | 188 | 229 | 10 | 6f8946d4710f6e32c937213f99b790b098b8819c |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | PTH2R SYNE2 PKHD1 ANK3 SNX29 SHANK2 FARP1 PRKCA MACF1 SLC4A4 | 6.32e-08 | 192 | 229 | 10 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | ANKS1B RPL10A DOCK5 COL24A1 FAT1 TPST2 FARP1 EXOC2 SLC4A4 RPL18A | 6.32e-08 | 192 | 229 | 10 | 4c9d748f209cc1e13d28c8c7f5180ab8522e0fbf |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ADGRV1 NECAB1 PIK3C2G PKHD1 ATP13A4 FAM184A ANK3 SHANK2 MICAL2 SLC4A4 | 6.32e-08 | 192 | 229 | 10 | fb2f0e897228f808d9ff734ad05e9b49dc38fa50 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | PTH2R SRGAP3 PKHD1 KIFC3 ANK3 DNAH7 SNX29 GRIP1 SHANK2 FARP1 | 7.31e-08 | 195 | 229 | 10 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 |
| ToppCell | healthy_donor-Lymphocytic-T_cell-Gamma_Delta_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 7.67e-08 | 196 | 229 | 10 | 6eabbac1625f715531bae562a28da27664572600 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.04e-08 | 197 | 229 | 10 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | TANC2 ADGRV1 DOCK5 NECAB1 ATP13A4 FAM184A ANK3 SHANK2 MICAL2 SLC4A4 | 8.84e-08 | 199 | 229 | 10 | 8587bd98de7767a575088afbea07a1feb4516b9b |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.30e-07 | 168 | 229 | 9 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | ANKS1B ADGRV1 ATP13A4 FAM184A ANK3 SYNE1 SHANK2 MICAL2 SLC4A4 | 2.30e-07 | 168 | 229 | 9 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.67e-07 | 171 | 229 | 9 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.40e-07 | 176 | 229 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-07 | 177 | 229 | 9 | 2f81b26be89cc2fd8eafadaf7eae3c6ad6521462 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 4.11e-07 | 180 | 229 | 9 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-07 | 181 | 229 | 9 | e2d03115a87f45a7ddd3ade6b9ac3843639bd41a | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-07 | 181 | 229 | 9 | d8d11ef83c4b8b6a6f5c8728e03059e45a8ad264 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.73e-07 | 183 | 229 | 9 | 91079a11685dd466bd27a0cf5afbf3734c08a05e | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 4.95e-07 | 184 | 229 | 9 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.18e-07 | 185 | 229 | 9 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | ADGRV1 PHKA1 PIK3C2G PKHD1 ATP13A4 FAM184A GRIP1 SHANK2 MICAL2 | 5.67e-07 | 187 | 229 | 9 | db2974e2e87ac9f1c2407a371d5ed89af09fc9b7 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.67e-07 | 187 | 229 | 9 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ADGRV1 NECAB1 PIK3C2G PKHD1 ATP13A4 FAM184A ANK3 SHANK2 SLC4A4 | 5.67e-07 | 187 | 229 | 9 | 5df9e1f5ca32217af255e76e6fb5afa346337811 |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|kidney / Disease (COVID-19 only), tissue and cell type | 5.67e-07 | 187 | 229 | 9 | 738ec2611b4be6a08eedad16b57fba84e1f11fef | |
| ToppCell | COVID-19-Epithelial_cells-Airway_basal|COVID-19 / group, cell type (main and fine annotations) | ANKRD18B FAT2 SRGAP3 SLITRK6 ATP13A4 ANK3 GRIP1 SHANK2 SLC4A4 | 5.67e-07 | 187 | 229 | 9 | 8407a82e98f56a94ea26562bcb6bbe00a8f41661 |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.92e-07 | 188 | 229 | 9 | 4bdf8d49af0e9da349b16e3f012e1b0eec04cc4f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.92e-07 | 188 | 229 | 9 | af740fa78542438fdff627ea1f74f4eee43316be | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.92e-07 | 188 | 229 | 9 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | ADGRV1 DOCK5 ATP13A4 FAM184A ANK3 SHANK2 MICAL2 FARP1 SLC4A4 | 5.92e-07 | 188 | 229 | 9 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | ADGRV1 NECAB1 PIK3C2G PKHD1 ATP13A4 FAM184A ANK3 SHANK2 SLC4A4 | 6.76e-07 | 191 | 229 | 9 | 34cc997e4e5c727495f321e6807a84aa124da486 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | ADGRV1 PANK1 NECAB1 ANKDD1B ATP13A4 FAM184A ANK3 PPP4R4 PRKCA | 7.07e-07 | 192 | 229 | 9 | cc9911e182a289779a2612bc213daae5607689e7 |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.38e-07 | 193 | 229 | 9 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.38e-07 | 193 | 229 | 9 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | ADGRV1 ATP13A4 FAM184A ANK3 SYNE1 SHANK2 MICAL2 FARP1 SLC4A4 | 7.70e-07 | 194 | 229 | 9 | 53f3e49e91b1096f3226010e2de767efb490dfe4 |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.70e-07 | 194 | 229 | 9 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 8.04e-07 | 195 | 229 | 9 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 8.04e-07 | 195 | 229 | 9 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.04e-07 | 195 | 229 | 9 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 8.39e-07 | 196 | 229 | 9 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 8.39e-07 | 196 | 229 | 9 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.13e-07 | 198 | 229 | 9 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 9.13e-07 | 198 | 229 | 9 | b598ab958e31f1e98bd06dc0097b58ac3a3f90a3 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.13e-07 | 198 | 229 | 9 | 1408e02e053ad3406229bfe8189da03be6366e81 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | TANC2 ADGRV1 NECAB1 ATP13A4 FAM184A PPP4R4 SHANK2 MICAL2 SLC4A4 | 9.13e-07 | 198 | 229 | 9 | f948391296c261c473d339069a6d0f20ccd6f38f |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 9.13e-07 | 198 | 229 | 9 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.52e-07 | 199 | 229 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.93e-07 | 200 | 229 | 9 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.93e-07 | 200 | 229 | 9 | 07d942803360e1a1e8e131d6e31c726dd0db1a0b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.93e-07 | 200 | 229 | 9 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 9.93e-07 | 200 | 229 | 9 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 9.93e-07 | 200 | 229 | 9 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | mild-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.93e-07 | 200 | 229 | 9 | d8aec4904c9420b8f9d7508658ba1e36c66cdfcc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.93e-07 | 200 | 229 | 9 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.51e-06 | 156 | 229 | 8 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 160 | 229 | 8 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-06 | 160 | 229 | 8 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.75e-06 | 169 | 229 | 8 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.88e-06 | 170 | 229 | 8 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 3.72e-06 | 176 | 229 | 8 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.21e-06 | 179 | 229 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.57e-06 | 181 | 229 | 8 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.96e-06 | 183 | 229 | 8 | 6847c1252d6bb105524f812658112517fd351eab | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 4.96e-06 | 183 | 229 | 8 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.96e-06 | 183 | 229 | 8 | facd6dbe0851b537d70a899ac7485714ab27d071 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3-Exc_L2-3_LINC00507_RPL9P17|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.96e-06 | 183 | 229 | 8 | 1645d4a55cd8c22d6eb47fc5c6b1e576c454f111 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.16e-06 | 184 | 229 | 8 | 34e316ad8e7b8667cd8ad61397281802a252744f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-06 | 184 | 229 | 8 | 9434731f651820b05335085582960f08fbf895de | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.16e-06 | 184 | 229 | 8 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 5.37e-06 | 185 | 229 | 8 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | COVID-19-kidney-Mito-rich_PCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.37e-06 | 185 | 229 | 8 | 1bbc2ba8a20f72f61981b1301cdd6018cdd9150d | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-06 | 185 | 229 | 8 | 8816f2909ed11833ff3d0ed96b9cb6d6fe9e1578 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-06 | 185 | 229 | 8 | a0a629e5d2b65f670ea907bd3f5e3caf17687d8f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.37e-06 | 185 | 229 | 8 | 34fcfd635c828dad9643bbf1c908d79282d6f5d9 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.37e-06 | 185 | 229 | 8 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.59e-06 | 186 | 229 | 8 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.59e-06 | 186 | 229 | 8 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_alveolar-distal-epi_SOX9^high_Etv5^high_distal_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 5.59e-06 | 186 | 229 | 8 | bb0bfe9a015151be08a6ffc5d82896d0556d76de | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.59e-06 | 186 | 229 | 8 | e83718fabb057100835d3357df407f283d23fe16 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.81e-06 | 187 | 229 | 8 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.87e-05 | 49 | 140 | 6 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Disease | Intellectual Disability | TANC2 RAB11B KDM5C RAB11A SRGAP3 DLG4 SYNE1 GTPBP2 POLR3B SHANK2 MACF1 VPS53 ZNF292 | 3.98e-05 | 447 | 223 | 13 | C3714756 |
| Disease | occipital horn syndrome (implicated_via_orthology) | 5.69e-05 | 2 | 223 | 2 | DOID:0111272 (implicated_via_orthology) | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 1.70e-04 | 3 | 223 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Charcot-Marie-Tooth disease X-linked recessive 5 (implicated_via_orthology) | 1.70e-04 | 3 | 223 | 2 | DOID:0110210 (implicated_via_orthology) | |
| Disease | Catecholaminergic polymorphic ventricular tachycardia 1 | 1.70e-04 | 3 | 223 | 2 | cv:C1631597 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY | 1.70e-04 | 3 | 223 | 2 | 604772 | |
| Disease | Hypothyroidism | 3.38e-04 | 4 | 223 | 2 | C0020676 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 3.38e-04 | 4 | 223 | 2 | cv:CN293514 | |
| Disease | Stress-induced polymorphic ventricular tachycardia | 3.38e-04 | 4 | 223 | 2 | C2677794 | |
| Disease | metal metabolism disorder (implicated_via_orthology) | 3.38e-04 | 4 | 223 | 2 | DOID:896 (implicated_via_orthology) | |
| Disease | PR interval | DYSF RYR2 STRN FAT1 SYNE2 SIPA1L2 RBP1 RIC8B MICAL2 LPIN2 PRKCA MACF1 | 4.19e-04 | 495 | 223 | 12 | EFO_0004462 |
| Disease | zinc transporter 3 measurement | 5.60e-04 | 5 | 223 | 2 | EFO_0803287 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 5.60e-04 | 5 | 223 | 2 | C1450051 | |
| Disease | Wilson disease (implicated_via_orthology) | 5.60e-04 | 5 | 223 | 2 | DOID:893 (implicated_via_orthology) | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 5.60e-04 | 5 | 223 | 2 | C0410190 | |
| Disease | serine/threonine-protein kinase Chk1 measurement | 5.60e-04 | 5 | 223 | 2 | EFO_0021965 | |
| Disease | Familial ventricular tachycardia | 5.60e-04 | 5 | 223 | 2 | C0340485 | |
| Disease | Menkes disease (implicated_via_orthology) | 5.60e-04 | 5 | 223 | 2 | DOID:1838 (implicated_via_orthology) | |
| Disease | Moyamoya disease (is_implicated_in) | 5.60e-04 | 5 | 223 | 2 | DOID:13099 (is_implicated_in) | |
| Disease | Neurodevelopmental Disorders | 7.14e-04 | 93 | 223 | 5 | C1535926 | |
| Disease | testosterone measurement | DCHS2 ACOT13 ANKS1B NLRC4 DOCK5 NFKB1 SYNE2 ANKDD1B ARHGEF6 FAM184A ANK3 DNAH2 CCDC85C PPARA RIC8B HMCN1 SEC23IP PRKCA MACF1 TNKS2 SPIN3 | 7.20e-04 | 1275 | 223 | 21 | EFO_0004908 |
| Disease | Emery-Dreifuss muscular dystrophy | 8.36e-04 | 6 | 223 | 2 | cv:C0410189 | |
| Disease | pre-mRNA-processing factor 6 measurement | 8.36e-04 | 6 | 223 | 2 | EFO_0802894 | |
| Disease | thymidine kinase, cytosolic measurement | 8.36e-04 | 6 | 223 | 2 | EFO_0020773 | |
| Disease | o-acetyl-ADP-ribose deacetylase MACROD1 measurement | 8.36e-04 | 6 | 223 | 2 | EFO_0802827 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 8.36e-04 | 6 | 223 | 2 | C0410189 | |
| Disease | ribosome biogenesis protein TSR3 homolog measurement | 8.36e-04 | 6 | 223 | 2 | EFO_0803025 | |
| Disease | CCAAT/enhancer-binding protein beta measurement | 8.36e-04 | 6 | 223 | 2 | EFO_0021905 | |
| Disease | leucine-rich repeat and fibronectin type III domain-containing protein 1 measurement | 8.36e-04 | 6 | 223 | 2 | EFO_0802689 | |
| Disease | leucine-rich repeat-containing protein 74A measurement | 8.36e-04 | 6 | 223 | 2 | EFO_0801763 | |
| Disease | secreted frizzled-related protein 2 measurement | 8.36e-04 | 6 | 223 | 2 | EFO_0802039 | |
| Disease | DNA-binding protein SATB2 measurement | 8.36e-04 | 6 | 223 | 2 | EFO_0802484 | |
| Disease | foot muscle strength measurement | 8.36e-04 | 6 | 223 | 2 | EFO_0009699 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 9.41e-04 | 148 | 223 | 6 | C0279702 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.02e-03 | 206 | 223 | 7 | C0152013 | |
| Disease | reticulocyte count | PRPSAP1 RAB11B USE1 RAB11A IST1 DOCK5 STRN FAT1 PTPRN NFKB1 SYNE2 SLC30A10 USP49 ANK1 MRPL4 PIKFYVE MICAL2 WDSUB1 | 1.05e-03 | 1045 | 223 | 18 | EFO_0007986 |
| Disease | Hereditary Autoinflammatory Diseases | 1.16e-03 | 7 | 223 | 2 | C0751422 | |
| Disease | myotubularin-related protein 1 measurement | 1.16e-03 | 7 | 223 | 2 | EFO_0802773 | |
| Disease | RNA polymerase II elongation factor ELL measurement | 1.16e-03 | 7 | 223 | 2 | EFO_0802028 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 1.16e-03 | 7 | 223 | 2 | C0751337 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 1.28e-03 | 157 | 223 | 6 | DOID:14330 (implicated_via_orthology) | |
| Disease | Hyperoxaluria | 1.55e-03 | 8 | 223 | 2 | C0020500 | |
| Disease | growth factor receptor-bound protein 7 measurement | 1.55e-03 | 8 | 223 | 2 | EFO_0801659 | |
| Disease | tumor necrosis factor receptor superfamily member 19L measurement | 1.55e-03 | 8 | 223 | 2 | EFO_0008309 | |
| Disease | Glioblastoma Multiforme | 1.58e-03 | 111 | 223 | 5 | C1621958 | |
| Disease | late-onset Alzheimers disease | 1.79e-03 | 292 | 223 | 8 | EFO_1001870 | |
| Disease | Todd Paralysis | 1.98e-03 | 9 | 223 | 2 | C0234544 | |
| Disease | cytochrome c oxidase subunit 4 isoform 2, mitochondrial measurement | 1.98e-03 | 9 | 223 | 2 | EFO_0801514 | |
| Disease | Paralysed | 1.98e-03 | 9 | 223 | 2 | C0522224 | |
| Disease | response to clopidogrel, response to acetylsalicylate, major adverse cardiovascular event measurement | 1.98e-03 | 9 | 223 | 2 | EFO_0020863, GO_1903492, GO_1903493 | |
| Disease | malaria (implicated_via_orthology) | 1.98e-03 | 9 | 223 | 2 | DOID:12365 (implicated_via_orthology) | |
| Disease | spinal muscular atrophy (implicated_via_orthology) | 1.98e-03 | 9 | 223 | 2 | DOID:12377 (implicated_via_orthology) | |
| Disease | Vasodilators used in cardiac diseases use measurement | 2.14e-03 | 34 | 223 | 3 | EFO_0009926 | |
| Disease | transcription factor IIIb 90 kda subunit measurement | 2.46e-03 | 10 | 223 | 2 | EFO_0020778 | |
| Disease | DNA-directed RNA polymerases I and III subunit RPAC1 measurement | 2.46e-03 | 10 | 223 | 2 | EFO_0801535 | |
| Disease | OCIA domain-containing protein 1 measurement | 2.46e-03 | 10 | 223 | 2 | EFO_0008252 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 2.46e-03 | 10 | 223 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 2.46e-03 | 10 | 223 | 2 | C1631597 | |
| Disease | Prostatic Neoplasms | ATP7B CHD1 GRHPR MYBBP1A ANXA1 PPFIBP2 AOX1 CASP9 PPARA PTRH2 CTBP2 ZNF292 | 2.69e-03 | 616 | 223 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | ATP7B CHD1 GRHPR MYBBP1A ANXA1 PPFIBP2 AOX1 CASP9 PPARA PTRH2 CTBP2 ZNF292 | 2.69e-03 | 616 | 223 | 12 | C0376358 |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 2.99e-03 | 11 | 223 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | Tachycardia, Ventricular | 2.99e-03 | 11 | 223 | 2 | C0042514 | |
| Disease | cytochrome p450 3a4 measurement | 2.99e-03 | 11 | 223 | 2 | EFO_0020303 | |
| Disease | guanylate-binding protein 6 measurement | 2.99e-03 | 11 | 223 | 2 | EFO_0801662 | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 3.57e-03 | 12 | 223 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | cataract (biomarker_via_orthology) | 4.20e-03 | 13 | 223 | 2 | DOID:83 (biomarker_via_orthology) | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 4.20e-03 | 13 | 223 | 2 | EFO_0802114 | |
| Disease | QRS complex, QRS duration | 4.78e-03 | 45 | 223 | 3 | EFO_0005054, EFO_0005055 | |
| Disease | Manganese Poisoning | 4.87e-03 | 14 | 223 | 2 | C0677050 | |
| Disease | diffuse large B-cell lymphoma | 4.87e-03 | 14 | 223 | 2 | EFO_0000403 | |
| Disease | diastolic blood pressure, systolic blood pressure | PSMD1 RYR2 DOCK5 ULK4 ANK3 DYNC2H1 DNAH2 CASQ2 DNAH7 FARP1 PRKCA LRRFIP1 | 5.23e-03 | 670 | 223 | 12 | EFO_0006335, EFO_0006336 |
| Disease | response to olanzapine | 5.60e-03 | 15 | 223 | 2 | GO_0097333 | |
| Disease | Hypertriglyceridemia | 5.60e-03 | 15 | 223 | 2 | C0020557 | |
| Disease | Hepatitis | 5.60e-03 | 15 | 223 | 2 | C0019158 | |
| Disease | Squamous cell carcinoma of esophagus | 5.91e-03 | 95 | 223 | 4 | C0279626 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.08e-03 | 152 | 223 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Seizures | 6.44e-03 | 218 | 223 | 6 | C0036572 | |
| Disease | reticulocyte measurement | PRPSAP1 RAB11B USE1 RAB11A IST1 PFAS DOCK5 FAT1 NFKB1 SYNE2 SLC30A10 ANK1 MRPL4 PIKFYVE MICAL2 LPIN2 | 6.59e-03 | 1053 | 223 | 16 | EFO_0010700 |
| Disease | RS-6-hydroxywarfarin measurement | 6.59e-03 | 155 | 223 | 5 | EFO_0803328 | |
| Disease | Glycogen storage disease | 7.18e-03 | 17 | 223 | 2 | cv:C0017919 | |
| Disease | muscular dystrophy (is_implicated_in) | 7.18e-03 | 17 | 223 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | Moyamoya Disease | 7.18e-03 | 17 | 223 | 2 | C0026654 | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 7.18e-03 | 17 | 223 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | monoclonal gammopathy | 7.56e-03 | 53 | 223 | 3 | EFO_0000203 | |
| Disease | Huntington's disease (is_marker_for) | 7.56e-03 | 53 | 223 | 3 | DOID:12858 (is_marker_for) | |
| Disease | abdominal adipose tissue measurement | 7.56e-03 | 53 | 223 | 3 | EFO_0803316 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AGAVEVAMAEALIKH | 411 | P40227 | |
| EMKVEEEHTNAIGTL | 41 | Q9NPJ3 | |
| VMLLAHGSKEEVNET | 766 | Q96P47 | |
| TIEAIHGLMSQVIKD | 311 | Q92905 | |
| MLIGKSHTEDDIIIA | 21 | P06276 | |
| IHDVVSELFMAGKEL | 436 | Q96N23 | |
| KTVEMTENGSHQLIV | 151 | Q15052 | |
| LMKSIHAGLNAVAAI | 81 | Q53TN4 | |
| ALQHKVVSSVAGLML | 446 | Q9NQ75 | |
| EIHEKVLNEAVGALM | 61 | Q13363 | |
| QEIHEKVLNEAVGAM | 66 | P56545 | |
| TGLLMDLAANEKAVH | 26 | Q8WXC6 | |
| LKMAHVGISLSEQEA | 856 | Q4VNC1 | |
| DHEMKGQTAILVAID | 1171 | P35670 | |
| LASKEGHVKMVVELL | 51 | P16157 | |
| TLHRMAEKVGADITV | 126 | Q9BX10 | |
| HGILEFADKQVTAMI | 3971 | Q8WXG9 | |
| DVGMIFHTIEQLTLK | 1421 | O15085 | |
| EVLHQELLSMGKVQE | 781 | A2A2Z9 | |
| AIAGDVNKVMESILL | 46 | A6NC57 | |
| DVIMHALTKQLEAVS | 146 | Q9Y2Z9 | |
| VSVLVQEGHAVSDML | 56 | Q9BXJ7 | |
| IHSVITAIGIKMEGL | 146 | Q9UHI6 | |
| LKEFGIVVHNEMTEL | 386 | Q9HCK5 | |
| KEAVLNGLVATEVLM | 71 | O75964 | |
| VLDHLVIQRMDTTGK | 931 | O14646 | |
| ASDLVLKASHIGMLQ | 376 | Q8NB25 | |
| DIIHDVGITVMIENL | 346 | Q6P1M9 | |
| HAEVMKKIIETVAEG | 266 | Q9NT62 | |
| AFKVVDQILEGEIHM | 731 | Q06278 | |
| AELAIHILKSMGLEV | 1236 | Q04656 | |
| ESLIVFMEQVHRGIK | 631 | Q8N436 | |
| NAMVAVKTVVHGLVD | 376 | Q9HBD1 | |
| DHADSNIVIMLVGNK | 111 | P62491 | |
| AQHDVALMLLGNKVD | 166 | Q9ULW5 | |
| DHADSNIVIMLVGNK | 111 | Q15907 | |
| VLQHLVVSAEMVGKA | 171 | Q96M98 | |
| VTELQGHVLMLIVKS | 1401 | O75747 | |
| TLEEQGVAHNVKAMV | 141 | Q9Y5A7 | |
| SDVAALHKAIMVKGV | 46 | P04083 | |
| LHKAIMVKGVDEATI | 51 | P04083 | |
| QATMVDIHILVGKGA | 401 | O75106 | |
| HKAVVQVLLEAGMDV | 206 | Q7Z6G8 | |
| MDSKANIVHGLSVLE | 311 | O43929 | |
| EFILVGLTDHQELKM | 11 | P0C7N1 | |
| LAENAPLHTLVMEVK | 2501 | Q14517 | |
| LGANILLETFKIHEM | 421 | Q9NVI1 | |
| GVKLLEILAEHVHMS | 486 | Q16849 | |
| MIASKEGHTEIVQDL | 241 | Q9ULH0 | |
| MGDLKSLVQLHVETQ | 831 | Q9HBG6 | |
| ALGIAHLIVMALEKE | 306 | P48163 | |
| SQHLVVAFGVELKEM | 241 | Q8N7X4 | |
| VEQDAARGIIHMILK | 46 | Q9NPP4 | |
| AIIHADLKPENIMLV | 131 | Q8NE63 | |
| LMLQAGHSDVVLVDT | 291 | A4FU01 | |
| GAHELEQMQLILETI | 231 | P31152 | |
| MLADIEIHSIGSIIA | 1136 | P46020 | |
| QHMVTGILKSIDIAH | 221 | Q9NR71 | |
| ATAMKLHGVIDILSL | 101 | P0CG22 | |
| QEFVGMLSTVKHEVI | 261 | Q96KR4 | |
| AVVHAMKVLEVHENL | 351 | A6NKD9 | |
| SQDVMEKLVLVLAHL | 1476 | Q8IY21 | |
| EILGNQIHMHVTAKE | 281 | Q13144 | |
| DLEMSGLKTLEHVAV | 516 | Q16549 | |
| VEVMAVAAKNVALLA | 456 | Q8NBM8 | |
| IQEVMHSLVKLTRGA | 506 | Q96KP1 | |
| AENAMVGTKVIDLLA | 2491 | Q9NYQ8 | |
| IHTLQGIESGILVAM | 106 | Q9UKL2 | |
| VHVGMDTAAKAIILE | 51 | A6NFU8 | |
| TADLDVHGKVLLMQK | 226 | Q8WVB3 | |
| ATIKRHEMTGDILVA | 166 | Q96JB8 | |
| EDSKHMVQIVGLQEL | 381 | Q5T7B8 | |
| SLDKEMAIGDHILQQ | 166 | Q8N9Z9 | |
| IGEMVLAIDSIHQLH | 181 | Q9Y5S2 | |
| IIDEAHNLIDTITGM | 391 | Q96FC9 | |
| KERVEAVNMAEGIIH | 576 | P38646 | |
| LEGHQVKLNAAEEML | 146 | Q8ND30 | |
| HNVLMADKAISGVLD | 2366 | Q9UPN3 | |
| LTKEQLHLVMQGDVI | 316 | Q9BQG0 | |
| IHIVMKSDKEIVGTL | 26 | Q9Y4Y9 | |
| HLSVMLKAAVLVANT | 381 | Q9NYA4 | |
| VEILADGQMLHIKKA | 3106 | Q96RW7 | |
| THGMVLQLLKAETED | 3486 | Q96RW7 | |
| MKTQHILTVLALDDG | 1686 | Q6V1P9 | |
| GQMTDLIHTEKDLVT | 26 | P13674 | |
| HKSFMGVAQILLDEL | 1351 | Q9UQ26 | |
| AIHEVMEQGRVTIAK | 421 | P25205 | |
| DLQLVTREAIGHMKE | 391 | Q3MIT2 | |
| QDMLLEHGITLVINV | 761 | Q9Y2I7 | |
| IVIGQVDMEALVEKH | 861 | Q8NCM8 | |
| VVEIQALRTDGEHMK | 341 | Q96EW2 | |
| IMQAVTLILEGEHNI | 556 | Q8IUR7 | |
| AEVLEHSGKMVLLFE | 2011 | P46100 | |
| EIMSLHEASEKAQVL | 331 | Q8NCX0 | |
| RGEKATISIQEHMAI | 6 | Q14184 | |
| ELSLQIGDTVHILEM | 26 | Q9H7D0 | |
| VEVTMSVHDEEGKLL | 466 | Q9H7D0 | |
| KDVGATAVHIQLIME | 916 | Q9H7D0 | |
| DSEVVDGLMLQHITL | 461 | O15228 | |
| HMNETGVHKTVDVLL | 381 | O14981 | |
| GLRKVMHINVAVETL | 236 | O75460 | |
| ALAEITEMVAQLHGT | 716 | Q9Y4F1 | |
| SQLDVTHKEVGMLHQ | 66 | Q96MT8 | |
| KMVLALLELAQQDHG | 211 | P55211 | |
| LINVVVAVLMKHLDD | 1721 | Q9P0X4 | |
| VKQMLIVITDGESHD | 916 | A8TX70 | |
| VLLHGSLKVEGMVAI | 311 | Q96SY0 | |
| ELERVMINSIHKVTG | 1146 | Q8WXX0 | |
| KVISTMSVGIDHLAL | 76 | Q9UBQ7 | |
| VLHMDGENFRIVLEK | 101 | Q9NVQ4 | |
| QKAEALDGAHLMQIL | 6 | O75936 | |
| DLIMTENEVGKIALH | 691 | Q9BTC0 | |
| MELLLKHGASIQAVT | 416 | Q12955 | |
| KILAVNSVGLEDVMH | 211 | P78352 | |
| MLTIGDVIKQLIEAH | 16 | Q9H9T3 | |
| LREHMTQLKEAAIGV | 171 | Q5VSG8 | |
| ILGILKAVNDSMHLI | 801 | O15068 | |
| INGESVLGLVHMDVV | 1006 | O60307 | |
| LTMAALGKDHVDIVA | 1436 | O75064 | |
| IGTVNDRLMHKLSVE | 141 | P53990 | |
| IHIEGRNASEQVKML | 136 | P50053 | |
| DLRHIVIDGSNVAMV | 436 | O15037 | |
| GLTHIITMDLHQKEI | 126 | Q14558 | |
| AQVLEHKAIGFVMVD | 81 | O14958 | |
| KAIHELIQVMAELSP | 131 | P01579 | |
| AVLKDEAMVLHLTLG | 1051 | Q9H583 | |
| AVDAMLLHGQDVITV | 86 | Q8N766 | |
| DAKGTVIHEVHVQMQ | 326 | Q66K89 | |
| AIHLLQMAGETVTLK | 736 | Q9Y3R0 | |
| LEQIVELGMDQHVEK | 1336 | Q9P225 | |
| TIQMLTEAVKEGSLH | 1791 | Q92736 | |
| QGSELHVVVKDHETM | 61 | O75923 | |
| VVEMSNLARQVLHGE | 116 | O95396 | |
| EMLEKHGIILNSEIA | 246 | Q32MZ4 | |
| LMLGVEIHVNVEFVK | 171 | O94851 | |
| THINEVMVLAGAVSV | 191 | A4D2G3 | |
| LLNVGHIEKMQEGIV | 391 | Q07869 | |
| TGIRDVHLELKNLTM | 286 | Q8TE04 | |
| DEMVKTGEAQIHAHL | 216 | Q9H488 | |
| EHVELVKRTMAGVSL | 136 | Q16626 | |
| EFILVGLTDHQELKM | 11 | Q8NH10 | |
| GKLIHSMVAHLEAVT | 696 | O43815 | |
| KALHLVDIQEAMATA | 276 | Q96DX7 | |
| KLIEVAEMHGELIEF | 591 | Q8TEQ0 | |
| KVREALHVAGVEMQL | 96 | Q6NUP7 | |
| VALTVKLAQDDLHIM | 176 | Q9BYD3 | |
| AGNIIHSLMKSDLVE | 371 | Q9H5Y7 | |
| VIDGMTVVHSIELQA | 166 | P45877 | |
| EVHKVEMFLGELLAA | 2556 | Q8NF91 | |
| TVAHIQDLTEKLGMI | 3306 | Q8WXH0 | |
| MTKLEEHLEGIVNIF | 1 | P80511 | |
| LLLLMVSHVKDSEGV | 111 | Q5T9Z0 | |
| LDNVMLDSEGHIKIA | 466 | P17252 | |
| RLMTHVDLGVKQIAA | 411 | Q9NVN3 | |
| KEIVQDGDHMIIRTL | 41 | P09455 | |
| TGMHRTEAIILVQKA | 156 | A6NCM1 | |
| QVEMKAVHENLAGVR | 351 | Q9BVG8 | |
| SDTHVKELMLLIIAG | 206 | P0C617 | |
| HMVILFTRKEELEGQ | 126 | Q8NHV1 | |
| AHLEGLMKDLNAITT | 1446 | Q92859 | |
| IKILSGEMAIELHLQ | 326 | Q99460 | |
| KVAVATLTHEQMIDL | 996 | Q9P2F8 | |
| VHETLVAVALGISMA | 206 | Q9BRY0 | |
| HEEVMQKIGELFALR | 346 | Q9NWS8 | |
| QIVDLLLTHGADVNM | 1081 | Q9HCD6 | |
| VLHLELKTVAHAGMV | 216 | Q9H4K7 | |
| IHLALTVMVSVLEKG | 3561 | P08F94 | |
| AIKELMTEGEHIATE | 896 | Q13017 | |
| IVEKVGMEINHLHAL | 551 | Q9Y6Y8 | |
| GEVTTMNHEDLSLLK | 481 | Q8IYB8 | |
| TELHDVLMKDVGNRI | 411 | A8MXQ7 | |
| LLNHKVHAVIGVLMD | 151 | P62191 | |
| AHSIQIMKVEEIAAS | 121 | Q02543 | |
| EIGVQHILADMIAKD | 366 | Q8N5C6 | |
| EGMEKIAERLQTTVH | 866 | Q8N5C6 | |
| TVMDVAHLAKHVQLV | 971 | Q5JTH9 | |
| HVQLVMEAIGKLSDD | 981 | Q5JTH9 | |
| AGLLMVHTVDATKLD | 1311 | Q9UPX8 | |
| ERGHVEMIEKLTFLN | 211 | A6NHY2 | |
| TVQARQVDMKLLEGH | 3861 | Q8IVF2 | |
| IIVHTMAAVEALGAK | 251 | O95573 | |
| EEVIKHLIMAVRGQF | 826 | P53675 | |
| DMNASAIQVLIEHIG | 1076 | P53675 | |
| MTKDNIGVAVVLEVH | 321 | Q96LI5 | |
| IELTKVHVERNAMDG | 581 | Q8NB49 | |
| DLTNHGIQAKEMITE | 326 | Q17RW2 | |
| AHAKMLGLTVSLIQD | 131 | Q9Y3E5 | |
| GTVTEMAIHAAAVLL | 4441 | Q63HN8 | |
| VGALEDMLQALKVHA | 36 | Q9NZ43 | |
| LLGMETEHQALLAKV | 236 | Q9NNX1 | |
| VLLHVMGDALGSVVV | 241 | Q6XR72 | |
| AMQAFILEVIAKHGE | 136 | O60704 | |
| GDLHVVLDMAKVADT | 141 | Q2NL82 | |
| DEKGEMQVVPVLVHL | 721 | P42285 | |
| LVEEGAVKRINMAHL | 431 | P11217 | |
| GLQMHEELLKVTNEL | 146 | O43295 | |
| RDLVVMLHKEGIQFS | 976 | Q9UJ98 | |
| VAMLGAVAAQEVLKA | 361 | P41226 | |
| LMRVSVGIHKEDIDA | 171 | P23921 | |
| LLLKVSAHITEQLGM | 151 | Q9H4I3 | |
| DTHLAEIMVGKAVEH | 121 | Q5JUX0 | |
| LVANMLSVAGADHII | 111 | P11908 | |
| VDGQKLVHSLFESIM | 241 | O15067 | |
| MDSVLIHVLIDGLVA | 1 | A6NMA1 | |
| TLVQVAHEKLMENGS | 131 | O60281 | |
| KIGVHVVFDQVLTME | 566 | Q70CQ1 | |
| VVEIKGHLDSMNVSL | 1341 | Q709C8 | |
| GLVKNLALMTHITTD | 491 | Q9NW08 | |
| EIQGKIEAVEMHLTR | 671 | Q9UKN8 | |
| VGAEQLLLDTHSLKM | 691 | Q5VIR6 | |
| VHAHIGVKELESLIM | 201 | P49190 | |
| AVAVGHVKMTDDELV | 166 | P62906 | |
| EAMELIVKLANHGLI | 211 | Q9BVS4 | |
| REQITLDVLVEMGHK | 896 | Q9H2K2 | |
| LVEQIETMGKLDEHQ | 61 | Q9BZ71 | |
| GQAALVELHSMEVIL | 301 | Q96JE7 | |
| QGMAEHLKDVILLTA | 96 | Q9BTX3 | |
| AIIISGTEMAKHIQK | 51 | Q9H903 | |
| DLHILKDAQVVGMTT | 971 | Q9P2E3 | |
| LLDHMKEHEGEIVNI | 926 | Q8TCN5 | |
| MEIHLQTNAEKGTIT | 141 | Q12931 | |
| LVANMLSVAGADHII | 111 | P60891 | |
| QLVEMIVDHQIETGL | 181 | Q9Y6R1 | |
| MVKLIHTLADHGDDV | 1 | Q8N9V3 | |
| TMLKAICVDVDHGLL | 61 | Q92748 | |
| LSGSHKALVEMQDVV | 311 | Q9C0H2 | |
| DLIIKHIGTSAIMDL | 151 | Q5H9R7 | |
| MDILATVNHGSIIKT | 61 | Q96PF2 | |
| LKNIEGELSSAIHMT | 1011 | Q6BDS2 | |
| GDILENIHEVMEIKF | 236 | P10600 | |
| LIVSMDVIQHETIGK | 111 | P13010 | |
| GEERVVNHMAAKIIE | 616 | Q96C45 | |
| ANVSKLVAHLEMIEG | 1896 | Q5THJ4 | |
| ESDTHAVQIALMALK | 541 | Q02108 | |
| AMHQIGDVKGVLEQV | 866 | P41229 | |
| DIEINGSAVDLHMKL | 66 | Q92539 | |
| QVKVASEALLIMDLH | 576 | Q5VVJ2 | |
| VTGDVKMLLAVQRHL | 521 | P19838 | |
| EIIEGNTKSHIMLVQ | 241 | Q8N987 |